MKI67 and cancer: Conversely, metformin significantly reduced CSC proliferation both in vitro and in immunodeficient xenograft mice models, as assessed by the Kiel 67 antigen Labelling Index (Ki-67-LI), a proliferation marker for several human and canine cancers [45].